Early Notification and Brand Change Rivastigmine Patches
As advised via PHARMAC Tender Results of 31 July 2019 there is to be a change in the listing and future sole supply of Rivastigmine Patches.
New listing from 1 January 2020
Rivastigmine Patch (Generic Partners) 4.6 mg per 24 hour, 30 pack Pharmacode TBA Schedule price $48.75
Rivastigmine Patch (Generic Partners) 9.5 mg per 24 hour, 30 pack Pharmacode TBA Schedule price $48.75
Exelon Patch 4.6 mg per 24 hour, 30 pack Pharmacode 2273616 Schedule price $90.00
Exelon Patch 9.5 mg per 24 hour, 30 pack Pharmacode 2273608 Schedule price $90.00
Reference pricing to apply 1 March 2020
HSS (Hospital Supply Status) 1 March 2020
CSS (Community Supply Status) 1 June 2020.
Brand switch fee not notified in July 2019 Tender.
As of the date of this notification ProPharma / PWR cannot accept Exelon Patches 4.6 mg or 9.5 mg for credit under any circumstances.
From 1 January 2020 community pharmacies dispensing Rivastigmine Patches will need to support patients changing to the new brand and manage stock during the transition.
We would recommend you continue to purchase the incumbent and we will change automatically as existing stocks are exhausted.
You MUST manage your stock to avoid being caught with stock at the time sole supply commences 1 March 2020 for DHB’s & 1 June 2020 Community Pharmacy. Failure to do so may prove very costly.
Once again we need your support to ensure stock in the supply chain moves through, to effectively ensure no losses are incurred by – supplier, wholesaler and pharmacy.
Together we can make this a seamless and painless transition.
We thank you in anticipation of your ongoing support.